These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 16895216)

  • 1. [Protective effect of ARB on vascular diseases].
    Kim-Mitsuyama S
    Nihon Rinsho; 2006 Jul; 64 Suppl 5():475-81. PubMed ID: 16895216
    [No Abstract]   [Full Text] [Related]  

  • 2. [Multiphasic action of AT1 receptor blockers and their therapeutic effects for cardiovascular diseases].
    Mitsuyama K
    Nihon Yakurigaku Zasshi; 2008 Mar; 131(3):176-7. PubMed ID: 18350678
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cerebroprotection with calcium channel blockers].
    Mogi M; Iwai M; Horiuchi M
    Nihon Rinsho; 2006 Jul; 64 Suppl 5():531-5. PubMed ID: 16895222
    [No Abstract]   [Full Text] [Related]  

  • 4. Should angiotensin II receptor blockers and statins be combined?
    Nickenig G
    Circulation; 2004 Aug; 110(8):1013-20. PubMed ID: 15326080
    [No Abstract]   [Full Text] [Related]  

  • 5. Simvastatin and losartan enhance nitric oxide and reduce oxidative stress in salt-induced hypertension.
    Bayorh MA; Ganafa AA; Eatman D; Walton M; Feuerstein GZ
    Am J Hypertens; 2005 Nov; 18(11):1496-502. PubMed ID: 16280288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of combined treatment with angiotensin II type 1 receptor blocker and statin on stent restenosis.
    Yoshikawa M; Nakamura K; Nagase S; Sakuragi S; Kusano KF; Matsubara H; Ohe T
    J Cardiovasc Pharmacol; 2009 Feb; 53(2):179-86. PubMed ID: 19188828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Higher small arterial elasticity in hypertensive patients treated with angiotensin II receptor blockers.
    Takeuchi K; Ideishi M; Tashiro T; Morishige N; Yamada T; Saku K; Urata H
    Hypertens Res; 2005 Aug; 28(8):639-44. PubMed ID: 16392767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anti-atherosclerotic effect].
    Takai S; Miyazaki M
    Nihon Rinsho; 2006 Jul; 64 Suppl 5():518-23. PubMed ID: 16895221
    [No Abstract]   [Full Text] [Related]  

  • 9. [Antioxidant action and sympatho-inhibitory effect of ARB].
    Hitooks Y; Sunagawa K
    Nihon Rinsho; 2006 Jul; 64 Suppl 5():487-92. PubMed ID: 16897884
    [No Abstract]   [Full Text] [Related]  

  • 10. Protective effects of angiotensin II interruption: evidence for antiinflammatory actions.
    Dagenais NJ; Jamali F
    Pharmacotherapy; 2005 Sep; 25(9):1213-29. PubMed ID: 16164395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cardio-protective effects of nitric oxide].
    Watanabe T; Kotooka N; Node K
    Nihon Rinsho; 2004 Sep; 62 Suppl 9():510-2. PubMed ID: 15506438
    [No Abstract]   [Full Text] [Related]  

  • 12. [Involvement of angiotensin II in pathogenesis of hypertension and target organ damage].
    Okigaki M; Iwasaka T
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():139-43. PubMed ID: 15171357
    [No Abstract]   [Full Text] [Related]  

  • 13. [Tissue angiotensin II generating system].
    Miyazaki M
    Nihon Rinsho; 2006 Jul; 64 Suppl 5():57-62. PubMed ID: 16895169
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of angiotensin receptor blockers on myocardial infarction: what are we to believe?
    Ker JA; Rheeder P
    Cardiovasc J S Afr; 2005; 16(2):81-2. PubMed ID: 15915272
    [No Abstract]   [Full Text] [Related]  

  • 15. [NO and atherosclerosis].
    Ohtani K; Egashira K
    Nihon Rinsho; 2004 Sep; 62 Suppl 9():544-7. PubMed ID: 15506446
    [No Abstract]   [Full Text] [Related]  

  • 16. Combined effects of an 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor and angiotensin II receptor antagonist on nitric oxide bioavailability and atherosclerotic change in myocardial infarction-prone Watanabe heritable hyperlipidemic rabbits.
    Imanishi T; Ikejima H; Tsujioka H; Kuroi A; Kobayashi K; Shiomi M; Muragaki Y; Mochizuki S; Goto M; Yoshida K; Akasaka T
    Hypertens Res; 2008 Jun; 31(6):1199-208. PubMed ID: 18716369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms for the clinical benefits of angiotensin II receptor blockers.
    Schmieder RE
    Am J Hypertens; 2005 May; 18(5 Pt 1):720-30. PubMed ID: 15882557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of hypertensive patients with impaired glucose tolerance (IGT)].
    Yoshida D; Higashiura K; Shimamoto K
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():533-7. PubMed ID: 15779436
    [No Abstract]   [Full Text] [Related]  

  • 20. [Antiinflammatory action of angiotensin receptor blocker].
    Katagiri T; Takei M; Sakurai M; Matsuyama T; Sakai T
    Nihon Rinsho; 2006 Jul; 64 Suppl 5():506-11. PubMed ID: 16895219
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.